MedPath
TGA Approval

TEVA-EVEROLIMUS everolimus 5 mg tablet blister pack (277302)

277302

TEVA-EVEROLIMUS everolimus 5 mg tablet blister pack

Medis Pharma Pty Ltd

April 20, 2017

Medicine

Medicine

Active

Registered

Product Information

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-PI-01613-1

Active Ingredients

everolimus

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TEVA-EVEROLIMUS everolimus 5 mg tablet blister pack (277302) - TGA 批准文号 | MedPath